Download PDF
Thromb Haemost 2009; 101(05): 797-798
DOI: 10.1160/TH09-03-0175
Editorial Focus
Schattauer GmbH

Methodological issues affecting estimates of bleeding risks and consequences after venous thromboembolism

Robert J. Glynn
1   Division of Preventive Medicine, Brigham & Women’s Hospital, Boston, Massachussetts, USA
› Author AffiliationsFinancial support: This work was supported by grants AG018833 and AG031061 from the National Institutes of Health.
Further Information

Publication History

Received: 19 March 2009

Accepted: 19 March 2009

Publication Date:
24 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Spencer FA, Gore JM, Reed G. et al. Venous thromboembolism and bleeding in a community setting: the Worcester Venous Thromboembolism Study. Thromb Haemost 2009; 101: 878-885.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Schulman S, Beyth RJ, Kearon C. et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ED.). Chest 2008; 133: 257S-298S.
    CrossrefPubMedGoogle Scholar
  • 3 Ruiz-Giménez N, Suárez C, González R. et al. Predictive variables for major bleedintg events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE registry. Thromb Haemost 2008; 100: 26-31.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Sesso HD, Gaziano JM, VanDenburgh M. et al. Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians’ Health Study. Control Clin Trials 2002; 23: 686-702.
    CrossrefPubMedGoogle Scholar
  • 5 Anderson Jr FA, Wheeler HB, Goldberg RJ. et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991; 151: 933-938.
    CrossrefPubMedGoogle Scholar
  • 6 Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?. Stat Med 1993; 12: 737-751.
    CrossrefPubMedGoogle Scholar
  • 7 Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005; 162: 975-982.
    CrossrefPubMedGoogle Scholar